Karo Pharma AB (KARO) - Financial and Strategic SWOT Analysis Review

Karo Pharma AB (KARO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on development and commercialization of pharmaceutical products. It provides prescription medicines and over-the-counter products to pharmacies and directly to the healthcare sector across various countries with the Nordic region and Europe as its core markets. The company has brands spanning six key categories which include intimate care, dermatology, foot care, Wellness, Rx pharma care, and Pain, cough & cold. Karo Pharma AB is headquartered in, Stockholm, Sweden.

Karo Pharma AB Key Recent Developments

Apr 29,2020: Karo : Interim report Q1 2020
Apr 29,2020: Karo Pharma: Interim report Q1 2020
Feb 19,2020: Karo Pharma: Year-end report 2019
Dec 11,2019: Asa Riisberg leaves the Board of Directors of Karo Pharma at her own request
Aug 14,2019: Jon Johnsson appointed new CFO of Karo Pharma

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 

 
Section 1 - About the Company
Karo Pharma AB - Key Facts
Karo Pharma AB - Key Employees
Karo Pharma AB - Key Employee Biographies
Karo Pharma AB - Major Products and Services
Karo Pharma AB - History
Karo Pharma AB - Company Statement
Karo Pharma AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Karo Pharma AB - Business Description
Business Segment: Hospital Supply
Overview
Performance
Business Segment: OTC (Over-the-counter Pharmaceuticals)
Overview
Performance
Business Segment: Rx (Prescription Pharmaceuticals)
Overview
Performance
Geographical Segment: Denmark
Performance
Geographical Segment: Finland
Performance
Geographical Segment: France
Performance
Geographical Segment: Norway
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: Rest of world
Performance
Geographical Segment: Sweden
Performance
Geographical Segment: The US
Performance
Karo Pharma AB - Corporate Strategy
Karo Pharma AB - SWOT Analysis
SWOT Analysis - Overview
Karo Pharma AB - Strengths
Karo Pharma AB - Weaknesses
Karo Pharma AB - Opportunities
Karo Pharma AB - Threats
Karo Pharma AB - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Karo Pharma AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 29, 2020: Karo : Interim report Q1 2020
Apr 29, 2020: Karo Pharma: Interim report Q1 2020
Feb 19, 2020: Karo Pharma: Year-end report 2019
Dec 11, 2019: Asa Riisberg leaves the Board of Directors of Karo Pharma at her own request
Aug 14, 2019: Jon Johnsson appointed new CFO of Karo Pharma
Jul 19, 2019: Karo Pharma: Interim report January – June 2019
Jul 19, 2019: Clarification of the statement in the interim report published 19 July 2019 regarding the rights issue with pre-emptive rights
Apr 26, 2019: Karo Pharma: Interim report the first quarter 2019
Apr 03, 2019: Karo Pharma Aktiebolag names Christoffer Lorenzen as CEO
Feb 14, 2019: Karo Pharma: Year end report 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


Karo Pharma AB, Key Facts
Karo Pharma AB, Key Employees
Karo Pharma AB, Key Employee Biographies
Karo Pharma AB, Major Products and Services
Karo Pharma AB, History
Karo Pharma AB, Subsidiaries
Karo Pharma AB, Key Competitors
Karo Pharma AB, Ratios based on current share price
Karo Pharma AB, Annual Ratios
Karo Pharma AB, Annual Ratios (Cont...1)
Karo Pharma AB, Annual Ratios (Cont...2)
Karo Pharma AB, Interim Ratios
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Karo Pharma AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures

 
Karo Pharma AB, Performance Chart (2015 - 2019)
Karo Pharma AB, Ratio Charts
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


Karoon Energy Ltd (KAR) - Financial and Strategic SWOT Analysis Review

Karoon Energy Ltd (KAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Karo Pharma AB (KARO) - Financial and Strategic SWOT Analysis Review

Karo Pharma AB (KARO) - Financial and Strategic SWOT Analysis Review

USD 125 View Report

Hansa Biopharma AB (HNSA) - Financial and Strategic SWOT Analysis Review

Hansa Biopharma AB (HNSA) - Financial and Strategic SWOT Analysis Review

USD 125 View Report

Karo Pharma AB Strategic Analysis Review- Karo Pharma AB SWOT, Outlook, Operations and Financial Profile

Karo Pharma AB Company Profile provides strategic analysis of Karo Pharma AB Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available